An automated system for dispensing methadone at home.
COPA, an Automated Medication Dispensing and Remote Management System for at Home Methadone Dispensing
['FUNDING_SBIR_2'] · BERKSHIRE BIOMEDICAL CORPORATION · NIH-10746866
This study is working on a new device called COPA that helps safely give liquid methadone to people with opioid use disorder, making it easier for them to get their medication, especially during times when clinics might be hard to reach.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BERKSHIRE BIOMEDICAL CORPORATION (nih funded) |
| Locations | 1 site (DALLAS, UNITED STATES) |
| Trial ID | NIH-10746866 on ClinicalTrials.gov |
What this research studies
This research focuses on developing the Computerized Oral Prescription Administration System (COPA), an automated device designed to dispense liquid medications, specifically methadone, for patients with opioid use disorder. The device ensures safe delivery through dual biometric verification, confirming the patient's identity via fingerprint and dentition. This innovation aims to improve access to methadone maintenance treatment, especially during the COVID-19 pandemic when traditional treatment facilities may be less accessible. The project includes designing, engineering, and testing the device before seeking FDA approval.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with opioid use disorder who require methadone maintenance treatment.
Not a fit: Patients who are not diagnosed with opioid use disorder or those who do not require methadone treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance access to methadone treatment for patients struggling with opioid use disorder, improving their health and social productivity.
How similar studies have performed: While the approach of using automated systems for medication dispensing is gaining traction, this specific application for methadone maintenance treatment is relatively novel and has not been extensively tested.
Where this research is happening
DALLAS, UNITED STATES
- BERKSHIRE BIOMEDICAL CORPORATION — DALLAS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: TIMBERLAKE, JOHN — BERKSHIRE BIOMEDICAL CORPORATION
- Study coordinator: TIMBERLAKE, JOHN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.